[1] [5] Currently available GLP-1 medications in the United States include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GLP-1/GIP receptor agonist
The FDAs action forced such sites to pull or hide these products
In patients with CKD who are at increased risk for cardiovascular events, use of a GLP-1 RA may reduce the risk of progression of albuminuria, cardiovascular events, or both
Regular blood work every 3-4 months helps catch any issues early
EAT can modulate local electrophysiological properties, such as the refractory periods of the atria and pulmonary veins, thereby sustaining AF
Consistent with this hypothesis, dietary methionine supplementation attenuates the development of steatohepatitis induced by high doses of NAM